Back to Stakeholders
Funding & InvestmentGovernment FundingGrants, Subsidies & Contracts
Funding & InvestmentGovernment Funding
Funding & Investment

VA Connecticut Healthcare System

5 Trials

The VA Connecticut Healthcare System provides comprehensive medical and mental health services to veterans across Connecticut, with campuses in West Haven and Newington. As part of the VA's expanding psychedelic research program, it participates in clinical trials investigating MDMA-assisted therapy and psilocybin for PTSD and related conditions affecting veterans.

Quick Facts

Type
government
Website
Visit

Sponsored Trials

2
CompletedII

Open Label Ketamine Treatment for Major Depressive Disorder in Veterans

Start Date
Compounds
Ketamine
CompletedII

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Start Date
Compounds
Ketamine

Collaborated Trials

3
WithdrawnII

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

Start Date
Compounds
Placebo, Psilocybin
RecruitingII

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Start Date
Compounds
Ketamine, Placebo
CompletedI

Ketamine for Depression and Alcohol Dependence

Start Date
Compounds
Ketamine